SPRAVATO® is the only FDA-approved ketamine treatment for adults with treatment-resistant depression used as either monotherapy or in conjunction with an oral antidepressant.

Aether Psychiatric Consultants is a REMS-certified Spravato® treatment center meaning that we meet the strict safety and monitoring requirements necessary to administer Spravato® (esketamine) in a controlled setting. This ensures that patients receive treatment with the highest standards of care, including medical supervision and a required two-hour observation period after each dose. Spravato® (esketamine) is a fast-acting treatment for depression that works differently from traditional antidepressants. While most medications can take weeks to show results, Spravato® can provide relief within days by targeting new pathways in the brain to help restore balance and improve mood.